BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17954810)

  • 1. Randomized clinical trial of homocysteine level lowering therapy and fractures.
    Sawka AM; Ray JG; Yi Q; Josse RG; Lonn E
    Arch Intern Med; 2007 Oct; 167(19):2136-9. PubMed ID: 17954810
    [No Abstract]   [Full Text] [Related]  

  • 2. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
    Clarke R; Collins R
    J Cardiovasc Risk; 1998 Aug; 5(4):249-55. PubMed ID: 9919473
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine trials--clear outcomes for complex reasons.
    Loscalzo J
    N Engl J Med; 2006 Apr; 354(15):1629-32. PubMed ID: 16531615
    [No Abstract]   [Full Text] [Related]  

  • 5. Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia.
    Levine J; Stahl Z; Sela BA; Ruderman V; Shumaico O; Babushkin I; Osher Y; Bersudsky Y; Belmaker RH
    Biol Psychiatry; 2006 Aug; 60(3):265-9. PubMed ID: 16412989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins.
    Siragusa S; Malato A; Cigna V; Anastasio R; Coco LL; Casuccio A; Ciaccio M
    Thromb Res; 2007; 121(1):51-3. PubMed ID: 17462714
    [No Abstract]   [Full Text] [Related]  

  • 7. Determining factors of the response to hyperhomocysteinemia treatment in renal transplant patients.
    Díaz JM; Sainz Z; Gich I; Guirado LL; Puig T; Oliver A; Montañés R; Facundo C; Chuy E; Solà R
    Transplant Proc; 2005 Nov; 37(9):3785-7. PubMed ID: 16386538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Homocysteinemia and vascular disease--a new risk factor is born].
    Reis RP; Luís AS
    Rev Port Cardiol; 1999 May; 18(5):507-14. PubMed ID: 10418265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Folic acid in hyperhomocysteinemia?].
    Stammler F
    Dtsch Med Wochenschr; 2005 Jun; 130(24):1518-9. PubMed ID: 15942844
    [No Abstract]   [Full Text] [Related]  

  • 10. A statement of homocyst(e)ine and cardiovascular disease.
    Heart and Stroke Foundation of Canada
    Can J Cardiol; 2001 Jul; 17(7):763-6. PubMed ID: 11515496
    [No Abstract]   [Full Text] [Related]  

  • 11. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
    Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
    G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine, B vitamins, and cardiovascular disease.
    Refsum H; Smith AD
    N Engl J Med; 2006 Jul; 355(2):207; author reply 209-11. PubMed ID: 16848014
    [No Abstract]   [Full Text] [Related]  

  • 13. Homocysteine, B vitamins, and cardiovascular disease.
    Wang X; Demirtas H; Xu X
    N Engl J Med; 2006 Jul; 355(2):207-9; author reply 209-11. PubMed ID: 16838445
    [No Abstract]   [Full Text] [Related]  

  • 14. Homocysteine, B vitamins, and cardiovascular disease.
    Quinlivan EP; Gregory JF
    N Engl J Med; 2006 Jul; 355(2):206; author reply 209-11. PubMed ID: 16838446
    [No Abstract]   [Full Text] [Related]  

  • 15. Homocysteine, B vitamins, and cardiovascular disease.
    Khare A; Lopez M; Gogtay J
    N Engl J Med; 2006 Jul; 355(2):206; author reply 209-11. PubMed ID: 16848015
    [No Abstract]   [Full Text] [Related]  

  • 16. Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients.
    Alvares Delfino VD; de Andrade Vianna AC; Mocelin AJ; Barbosa DS; Mise RA; Matsuo T
    Nutrition; 2007 Mar; 23(3):242-7. PubMed ID: 17321110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment.
    Boxer AL; Kramer JH; Johnston K; Goldman J; Finley R; Miller BL
    Neurology; 2005 Apr; 64(8):1431-4. PubMed ID: 15851736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lowering plasma homocysteine.
    Med Lett Drugs Ther; 2003 Oct; 45(1168):85-6. PubMed ID: 14576622
    [No Abstract]   [Full Text] [Related]  

  • 19. Homocysteine, B vitamins, and cardiovascular disease.
    Tomlinson DR; Lang D; Lewis MJ
    N Engl J Med; 2006 Jul; 355(2):209; author reply 209-11. PubMed ID: 16838444
    [No Abstract]   [Full Text] [Related]  

  • 20. Homocysteine, B vitamins, and cardiovascular disease.
    de Craen AJ; Stott DJ; Westendorp RG
    N Engl J Med; 2006 Jul; 355(2):205-6; author reply 209-11. PubMed ID: 16837687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.